Awards Given at ESH Meetings

The European Society of Hypertension confers the following awards each year at their annual meeting.

Björn Folkow Award and Lecture
Established by the ESH with the generous collaboration of AstraZeneca in 1989, it continues to be awarded to a person or persons for their outstanding contribution to basic or clinical research in hypertension. 

– 1989: J. Conway (Oxford, UK)
– 1991: M.A.D.H. Schalekamp (Rotterdam, The Netherlands)
– 1993: M.J. Mulvany (Aarhus, Denmark)
– 1995: P.I. Korner (Woolwich, Australia)
– 1997: G. Mancia (Milan, Italy)
– 1999: T. Unger (Berlin, Germany)
– 2000: M. O’Rourke (Darlinghurst, Australia)
– 2001: T.F. Lüscher (Zurich, Switzerland)
– 2003: F.C. Luft (Berlin, Germany)
– 2004: R. Fagard (Leuven, Belgium)
– 2005: H. Haller (Hannover, Germany)
– 2006: A.M. Heagerty (Manchester, UK)
– 2007: C.E. Morgensen (Aarhus, Denmark)
– 2008: A.F. Dominiczak (Glasgow, UK)
– 2009: G. Grassi (Milan, Italy)
– 2010: E. Schiffrin (Montreal, Canada)
– 2011: P.M. de Leeuw (Maastricht, The Netherlands)
– 2012: M.D. Esler (Melbourne, Australia)
– 2013: S. Laurent (Paris, France)
– 2014: G.L. Jennings (Melbourne, Australia)
– 2015: G. Parati (Milan, Italy)
– 2016: M.J. Caulfield (London, UK)
– 2017: X. Jeunemaitre (Paris, France)
– 2018: D.N. Müller (Berlin, Germany)
– 2019: J. Redon (Valencia, Spain)
– 2021: M. Schlaich (Perth, Australia)
– 2022: C. Thomopoulos (Athens, Greece)
– 2023: M. Burnier (Lausanne, Switzerland)

Alberto Zanchetti Life Achievement Award
Established by the ESH in 1995, the Alberto Zanchetti Life Achievement Award is conferred to a scientist with a life-long high quality scientific research in the field of hypertension.

– 1995: Y.V. Postnov (Moscow, Russia)
– 1997: H.R. Brunner (Lausanne, Switzerland)
– 1999: M. Safar (Paris, France)
– 2001: P.A. van Zwieten (Amsterdam, The Netherlands)
– 2003: A.F. Lever (Glasgow, UK)
– 2004: W.H. Birkenhager (Rotterdam, The Netherlands)
– 2005: P. Sleight (Oxford, UK)
– 2006: E. Ritz (Germany)
– 2007: K.H. Rahn (Münster, Germany)
– 2008: J. Chalmers (Sydney, Australia)
– 2009: P. Corvol (Paris, France)
– 2010: S. Julius (Ann Arbor, USA)
– 2011: A.L. Mark (Iowa City, USA)
– 2012: R.H. Fagard (Leuven, Belgium)
– 2013: W. Januszewicz (Warsaw, Poland)
– 2014: E. Ritz (Heidelberg, Germany)
– 2015: F.H. Messerli (New York, USA)
– 2016: J. Menard (Paris, France)
– 2018: S.E. Kjeldsen (Oslo, Norway)
– 2019: G. Mancia (Milan, Italy)
– 2021: P. Palatini (Padova, Italy)
– 2022: P. López-Jaramillo (Bucaramanga, Colombia)
– 2023: R. Schmieder (Erlangen, Germany)

ESH Honorary Membership
Established by the ESH in 2001, honorary membership is granted to a scientist who has made extraordinary contributions to research in hypertension or who has given exceptionally important support to the activities of the Society.

– 2001: P. Sleight (Oxford, UK)
– 2005: S. Julius (Ann Arbor, USA), B.N.C. Prichard (London, UK)
– 2006: A. Zanchetti (Milan, Italy)
– 2007: P. Lund-Johansen (Bergen, Norway), J. Widimský Sr. (Prague, Czech Republic)
– 2008: L. Lisheng (Beijing, China)
– 2009: J.L. Rodicio (Madrid, Spain), P. van Zwieten (Amsterdam, The Netherlands)
– 2010: D. Ganten (Berlin, Germany)
– 2011: D.L. Clement (Gent, Belgium)
– 2012: G. Mancia (Milano, Italy)
– 2013: T. Fujita (Tokyo, Japan)
– 2014: C. Farsang (Budapest, Hungary)
– 2016: J. Redon (Valencia, Spain)
– 2018: P. López-Jaramillo (Bucaramanga, Colombia)
– 2019: R. Cífková (Prague, Czech Republic)
– 2021: P.K. Whelton (New Orleans, USA)
– 2022: V. S. Ram (Hyderabad, India), B. Falkner (Philadelphia, USA)
– 2023: E. Agabiti Rosei (Brescia, Italy)

Paul Milliez Award
The Paul Milliez Award, established by the French Society of Hypertension (SFHTA ) and the ESH in 2004, continues to be awarded to a distinguished scientist/physician originating from a French speaking country in recognition of their outstanding contribution to research/education or care in the field of hypertension and related diseases.

– 2004: M. Safar (Paris, France)
– 2005: J. Ménard (Paris, France)
– 2006: P. Corvol (Paris, France)
– 2007: A. Mimran (Montpellier, France)
– 2008: B.I. Levy (Paris, France)
– 2009: J-M. Mallion (Grenoble, France)
– 2010: G. London (Fleury-Mérogis, France)
– 2011: P.F. Plouin (Paris, France)
– 2012: S. Laurent (Paris, France)
– 2013: J.L. Elghozi (Paris, France)
– 2014: F. Zannad (Nancy, France)
– 2017: M. Azizi (Paris, France)
– 2018: M. Beaufils (Paris, France)
– 2019: B. Chamontin (Toulouse, France)
– 2020: X. Girerd (Paris, France) 
– 2022: P. Gosse (Bordeaux, France)

Servier Research Grant in Hypertension
This initiative follows the Servier SNS Research Award and is awarded every 2 years for a research proposal in the field of hypertension and related diseases with a focus on end-organ damage, surrogate markers and biomarkers.

– 2011: K.E. Kotliar (Munich, Germany)
– 2013: S. Masi (London, U.K.)
– 2015: S. Foulquier (Maastricht, The Netherlands)
– 2017: D. Hering (Gdansk, Poland)
– 2019: M. Tadic (Berlin, Germany)
– 2021: R. Boulestreau (Bordeaux, France)
– 2023: E. Algharably (Berlin, Germany)

Peter A. van Zwieten Award
This award is dedicated to the late Prof. Peter A. van Zwieten in recognition of his exceptionally important support to the activities of the Society. This award is given every 2 years to a scientist with accomplishments in the field of cardiovascular pharmacology.

– 2011: M. Azizi (Paris, France)
– 2013: M. Burnier (Lausanne, Switzerland)
– 2015: A.H.J. Danser (Rotterdam, Netherlands)
– 2017: T. Unger (Maastricht, The Netherlands)
– 2019: M. Fernández-Alfonso (Madrid, Spain)
– 2021: M. Volpe (Rome, Italy)
– 2023: J. Versmissen (Rotterdam, The Netherlands)